Home › Non-Muscle Invasive Bladder Cancer › Oregon › Portland
Non-Muscle Invasive Bladder Cancer clinical trials in Portland, OR
3 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
RecruitingPhase 1
- Oregon Health & Science University, Portland
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecruitingPhase 2
- OHSU Knight Cancer Institute - South Waterfront ( Site 0110), Portland
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- Oregon Health & Science University (OHSU), Portland
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC10 studies
- Nashville, TN9 studies
- Edison, NJ9 studies
- Syracuse, NY9 studies
- Austin, TX8 studies
- Philadelphia, PA8 studies
- Houston, TX7 studies
- Birmingham, AL7 studies
- Atlanta, GA7 studies
Other studies in Portland
- Non-Small Cell Lung Cancer49 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Ovarian Cancer28 studies
- Colorectal Cancer28 studies
- Lung Cancer27 studies
- Acute Myeloid Leukemia24 studies
- Endometrial Cancer24 studies
- Pancreatic Cancer19 studies
- Head and Neck Squamous Cell Carcinoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.